2022.10.28 亚虹医药发布公告称:2022年Q3实现销售收入7,795.8元,YoY+14.91%,归母净利润-7321.09万元,YoY-59.50%,扣非后净利润-8933.73万元,YoY-83.04%,EPS -0.13元。研发费用7851.05万元,YoY+111.97%。
2022.10.28 亚虹医药发布公告称:2022年Q3实现销售收入7,795.8元,YoY+14.91%,归母净利润-7321.09万元,YoY-59.50%,扣非后净利润-8933.73万元,YoY-83.04%,EPS -0.13元。研发费用7851.05万元,YoY+111.97%。